(Q35009328)

5 August 2017

1 reference

title

Clinical use of tumor markers in childhood malignancies (English)

1 reference

5 August 2017

Pekka Labdenne

1

1 reference

5 August 2017

Markku Heikinheimo

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

34

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

316-323

1 reference

Neuron-specific enolase in relation to differentiation in human neuroblastoma

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Determination of urinary homovanillic and vanillylmandelic acids from dried filter paper samples: assessment of potential methods for neuroblastoma screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Screening of infants and mortality due to neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Mammalian cell growth proteins. I. Growth stimulation of fetuin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Hereditary tyrosinaemia type I: from basics to progress in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131-labeled anti-alpha-fetoprotein monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Colorectal carcinoma antigens detected by hybridoma antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Serum CA 125 levels in children with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Neuroblastoma Screening at One Year of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Neuron-specific enolase is produced by neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

A population-based study of the usefulness of screening for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Secretion of chromogranin A by peptide-producing endocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Prognostic factors and staging systems in childhood hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Proceedings of an international research workshop on pediatric liver tumours, 18-20 March 1999, Berne, Switzerland. Into the year 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Tumor markers at the time of recurrence in patients with germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(alpha-fetoprotein) Fab' fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Anti-alpha-fetoprotein imaging is useful for staging hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Tumour markers CA 19-9 and CA 50 in digestive tract malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Concentration and localization of carbohydrate antigen 19-9 in tissues of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

A critical analysis of the use of sialic acid determination in the diagnosis of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F078538902320772070

10.1080/078538902320772070

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference